Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1156 AL 1170

alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach

Bazzu G, Calia G, Puggioni G, Spissu Y, Rocchitta G, Debetto P, Grigoletto J, Zusso M, Migheli R, Serra PA, Desole MS, Miele E.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):482-90. doi: 10.2174/187152710791556177.

The role of phosphorylation in synucleinopathies: focus on Parkinson's disease

Cavallarin N, Vicario M, Negro A.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):471-81. doi: 10.2174/187152710791556140.

The epidemiology of dementia associated with Parkinson's disease

Aarsland D, Kurz MW.

Brain Pathol. 2010 May;20(3):633-9. doi: 10.1111/j.1750-3639.2009.00369.x.

Profile of cognitive impairment in Parkinson's disease

Watson GS, Leverenz JB.

Brain Pathol. 2010 May;20(3):640-5. doi: 10.1111/j.1750-3639.2010.00373.x.

Neuroimaging and cognition in Parkinson's disease dementia

Silbert LC, Kaye J.

Brain Pathol. 2010 May;20(3):646-53. doi: 10.1111/j.1750-3639.2009.00368.x.

Pathologic correlates of dementia in individuals with Lewy body disease

Sonnen JA, Postupna N, Larson EB, Crane PK, Rose SE, Montine KS, Leverenz JB, Montine TJ.

Brain Pathol. 2010 May;20(3):654-9. doi: 10.1111/j.1750-3639.2009.00371.x.

Biomarkers for cognitive impairment in Parkinson disease

Shi M, Huber BR, Zhang J.

Brain Pathol. 2010 May;20(3):660-71. doi: 10.1111/j.1750-3639.2009.00370.x.

The treatment of cognitive impairment associated with Parkinson's disease

Burn DJ.

Brain Pathol. 2010 May;20(3):672-8. doi: 10.1111/j.1750-3639.2009.00367.x.

Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living

Olin JT, Aarsland D, Meng X.

Dement Geriatr Cogn Disord. 2010;29(6):510-5. doi: 10.1159/000305100. Epub 2010 Jun 5.

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

Kosloski LM, Ha DM, Hutter JA, Stone DK, Pichler MR, Reynolds AD, Gendelman HE, Mosley RL.

J Neurochem. 2010 Sep 1;114(5):1261-76. doi: 10.1111/j.1471-4159.2010.06834.x. Epub 2010 May 26.

REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management

Trotti LM.

Drugs Aging. 2010 Jun 1;27(6):457-70. doi: 10.2165/11536260-000000000-00000.

[Disruptive nocturnal behavior in elderly subjects: could it be a parasomnia?]

Leu-Semenescu S, Arnulf I.

Psychol Neuropsychiatr Vieil. 2010 Jun;8(2):97-109. doi: 10.1684/pnv.2010.0210.

Ethical perspectives on relations between industry and neuropsychiatric medicine

Orfei MD, Caltagirone C, Spalletta G.

Int Rev Psychiatry. 2010;22(3):281-7. doi: 10.3109/09540261.2010.484014.

Significance of SGK1 in the regulation of neuronal function

Lang F, Strutz-Seebohm N, Seebohm G, Lang UE.

J Physiol. 2010 Sep 15;588(Pt 18):3349-54. doi: 10.1113/jphysiol.2010.190926. Epub 2010 Jun 7.

Genetics of caffeine consumption and responses to caffeine

Yang A, Palmer AA, de Wit H.

Psychopharmacology (Berl). 2010 Aug;211(3):245-57. doi: 10.1007/s00213-010-1900-1. Epub 2010 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias